Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Recognition and management of significant drug interactions in HIV patients: challenges in using available data to guide therapy.

Pau AK, Boyd SD.

Clin Pharmacol Ther. 2010 Nov;88(5):712-9. doi: 10.1038/clpt.2010.130. Epub 2010 Jul 28.

PMID:
20668439
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.

[No authors listed]

Prescrire Int. 2004 Aug;13(72):144-50.

PMID:
15532140
[PubMed - indexed for MEDLINE]
3.

Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.

Seden K, Back D.

Curr Opin HIV AIDS. 2011 Nov;6(6):514-26. doi: 10.1097/COH.0b013e32834b54dc. Review.

PMID:
22001895
[PubMed - indexed for MEDLINE]
4.

Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions.

[No authors listed]

Prescrire Int. 2008 Jun;17(95):98-101.

PMID:
18623908
[PubMed - indexed for MEDLINE]
5.

Delavirdine: a review of its use in HIV infection.

Scott LJ, Perry CM.

Drugs. 2000 Dec;60(6):1411-44. Review.

PMID:
11152019
[PubMed - indexed for MEDLINE]
6.

Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.

van Heeswijk RP, Veldkamp A, Mulder JW, Meenhorst PL, Lange JM, Beijnen JH, Hoetelmans RM.

Antivir Ther. 2001 Dec;6(4):201-29. Review.

PMID:
11878403
[PubMed - indexed for MEDLINE]
7.

Common adverse effects of antiretroviral therapy for HIV disease.

Reust CE.

Am Fam Physician. 2011 Jun 15;83(12):1443-51. Erratum in: Am Fam Physician. 2011 Jul 15;84(2):154.

PMID:
21671545
[PubMed - indexed for MEDLINE]
Free Article
8.

Interactions between recreational drugs and antiretroviral agents.

Antoniou T, Tseng AL.

Ann Pharmacother. 2002 Oct;36(10):1598-613. Review.

PMID:
12243611
[PubMed - indexed for MEDLINE]
9.

Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.

Joly V, Yeni P.

Antivir Ther. 2005;10(1):29-40. Review.

PMID:
15751761
[PubMed - indexed for MEDLINE]
10.

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C.

Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Review.

PMID:
20731472
[PubMed - indexed for MEDLINE]
11.

Antiretroviral prescribing errors in hospitalized patients.

Purdy BD, Raymond AM, Lesar TS.

Ann Pharmacother. 2000 Jul-Aug;34(7-8):833-8.

PMID:
10928390
[PubMed - indexed for MEDLINE]
12.

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Pinheiro Edos S, Antunes OA, Fortunak JM.

Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2. Review.

PMID:
18571246
[PubMed - indexed for MEDLINE]
13.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
[PubMed - indexed for MEDLINE]
14.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
[PubMed - indexed for MEDLINE]
15.

Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.

Patel N, Abdelsayed S, Veve M, Miller CD.

Ann Pharmacother. 2011 Mar;45(3):317-24. doi: 10.1345/aph.1P576. Epub 2011 Mar 8.

PMID:
21386025
[PubMed - indexed for MEDLINE]
16.

Frequency and nature of drug-drug interactions in a Dutch university hospital.

Zwart-van Rijkom JE, Uijtendaal EV, ten Berg MJ, van Solinge WW, Egberts AC.

Br J Clin Pharmacol. 2009 Aug;68(2):187-93. doi: 10.1111/j.1365-2125.2009.03443.x.

PMID:
19694737
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.

Rodríguez-Torres M.

Curr Opin Infect Dis. 2013 Feb;26(1):50-7. doi: 10.1097/QCO.0b013e32835c2027. Review.

PMID:
23242341
[PubMed - indexed for MEDLINE]
18.

Abacavir: new preparation. Risks limit the value.

[No authors listed]

Prescrire Int. 2000 Jun;9(47):67-9.

PMID:
11010740
[PubMed - indexed for MEDLINE]
19.

[Intolerance to and/or drug interactions of anti-HIV and anti-HVC therapy].

Galpérine T, Merle C, de Truchis P, Bernard L, Perronne C.

Med Mal Infect. 2005 Mar;35(3):135-40. Review. French.

PMID:
15911183
[PubMed - indexed for MEDLINE]
20.

Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy era.

Boyd MA, Hill AM.

Pharmacoeconomics. 2010;28 Suppl 1:17-34. doi: 10.2165/11587420-000000000-00000. Review.

PMID:
21182341
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk